NNVC is a valid developmental stage company with products of good demonstrated efficacies.
I will rely on actual real news concerning NNVC and not interpretations of either here or there. I would recommend others do also, but it is clearly a personal choice. I have been holding NNVC for a long time and weathered its ups and downs. I think the next 24 months will be the most interesting and I am more than willing to ride the waves that NNVC (just like many other companies) will have to navigate over that period.
NNVC has a wonderful track record in demonstrating the efficacy of their therapeutics. I agree with some of the concerns over timetables and execution proficiencies. But all in all, I believe the tox studies will get done, maybe later that I would have liked, I also believe NNVC will get to human phase studies. I have no problem waiting for that as I am fairly certain we will see that end within the next 24 months. While that might sound like a long time, it really is not. I have personally worked on R&D projects that have gone on for many years and seen the 24 month end-game scenario come subsequent to those many years of work. In retrospect, that period went in what seemed like a flash.
I also think we will see more secondary confirmations from the world class research from Dr. Eva Harris and also from Europe's world class investigators like ViroClinics coming in the meantime.
That will be real information you can count on. Between now and then, NNVC will likely undergo a lot of volatility. If someone is a trader, then that presents opportunity. I am not much of an active trader, and have no problem relaxing with a nice cold beer in the meantime.
Good luck to all those out there who might share my honest assessment.
As usual, wishing all the best of good buys!
HS
